Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2017Neuro-OncologyOpen Access

Is the blood–brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJann N. SarkariaMayo Clinic in ArizonaLHLeland HuWinnMedIPIan F. ParneyMayo Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sarkaria et al. (2017) studied this question.

synapsesocial.com/papers/69d8a2748c03fbaff8befb9dhttps://doi.org/10.1093/neuonc/nox175
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy2014 · 185 citations
  2. 2Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma2003 · 1,323 citations
  3. 3AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme2011 · 194 citations